We defined an early-stage tumor (low tumor, 5%–15% Eμ-Myc of CD45+ cells) and a progressed tumor stage (30%–50% Eμ-Myc cells, referred to as medium tumor or solely “tumor”) (Figures 1A, S1A, and S1B). Here, PTPRC is linked to neoplasm.